ES2112818T3 - Composicion farmaceutica que comprende lactobacillus plantarum y arginina. - Google Patents

Composicion farmaceutica que comprende lactobacillus plantarum y arginina.

Info

Publication number
ES2112818T3
ES2112818T3 ES96914505T ES96914505T ES2112818T3 ES 2112818 T3 ES2112818 T3 ES 2112818T3 ES 96914505 T ES96914505 T ES 96914505T ES 96914505 T ES96914505 T ES 96914505T ES 2112818 T3 ES2112818 T3 ES 2112818T3
Authority
ES
Spain
Prior art keywords
pharmaceutical composition
lactobacillus plantarum
arginina
includes lactobacillus
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96914505T
Other languages
English (en)
Other versions
ES2112818T1 (es
Inventor
Diya Adawi
Bengt Jeppson
Goran Molin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Probi AB
Original Assignee
Probi AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probi AB filed Critical Probi AB
Publication of ES2112818T1 publication Critical patent/ES2112818T1/es
Application granted granted Critical
Publication of ES2112818T3 publication Critical patent/ES2112818T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

LA INVENCION SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE UNA CEPA DE LACTOBACILLUS PLANTARUM QUE TIENE LA CAPACIDAD DE COLONIZAR LA MUCOSA INTESTINAL HUMANA IN VIVO, EN COMBINACION CON ARGININA Y UN VEHICULO FARMACEUTICAMENTE ACEPTABLE. LA COMPOSICION PUEDE UTILIZARSE PARA EL TRATAMIENTO CURATIVO Y/O PROFILACTICO DE LAS LESIONES HEPATICAS E INSUFICIENCIA HEPATICA Y TRANSLOCACION BACTERIANA ASOCIADA EN MAMIFEROS INCLUYENDO EL HOMBRE.
ES96914505T 1995-05-09 1996-05-08 Composicion farmaceutica que comprende lactobacillus plantarum y arginina. Expired - Lifetime ES2112818T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9501719A SE9501719D0 (sv) 1995-05-09 1995-05-09 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
ES2112818T1 ES2112818T1 (es) 1998-04-16
ES2112818T3 true ES2112818T3 (es) 2003-02-16

Family

ID=20398250

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96914505T Expired - Lifetime ES2112818T3 (es) 1995-05-09 1996-05-08 Composicion farmaceutica que comprende lactobacillus plantarum y arginina.

Country Status (16)

Country Link
EP (1) EP0825869B1 (es)
JP (1) JP4058560B2 (es)
KR (1) KR19990008403A (es)
CN (1) CN1152678C (es)
AT (1) ATE221783T1 (es)
AU (1) AU704886B2 (es)
BR (1) BR9608284A (es)
CA (1) CA2220498A1 (es)
DE (2) DE69622855T2 (es)
EE (1) EE03597B1 (es)
ES (1) ES2112818T3 (es)
GR (1) GR980300028T1 (es)
NO (1) NO317668B1 (es)
PL (1) PL184603B1 (es)
SE (1) SE9501719D0 (es)
WO (1) WO1996035440A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100376954B1 (ko) * 1995-07-31 2003-07-18 프로비 에이비 장에서집락화하는유산간균
MXPA02009342A (es) 2000-03-24 2003-09-22 Nestle Sa Uso de bacterias de acido lactico para el tratamiento de la peritonitis.
KR100585391B1 (ko) * 2002-01-24 2006-06-01 주식회사 프로바이오닉 돼지 전염성위장염 (TGE) 코로나바이러스 및 유해 미생물 억제 활성을 갖는 신규 락토바실러스 프란타럼 Probio-38 및 이를 함유하는 생균활성제
SE527555C2 (sv) * 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
US20070224285A1 (en) * 2004-03-31 2007-09-27 Calpis Co., Ltd Agent for Preventing or Suppressing Hepatopathy and Functional Food for Preventing or Suppressing Hepatopathy
KR100592717B1 (ko) * 2004-11-20 2006-06-26 주식회사 알엔에이 간 손상 보호 및 예방에 유용한 활성을 갖는 조성물
CN1322111C (zh) * 2004-12-17 2007-06-20 上海交大昂立股份有限公司 一种植物乳杆菌
CN100337653C (zh) * 2004-12-21 2007-09-19 上海交大昂立股份有限公司 一种含有植物乳杆菌的组合物
EP2277524B1 (en) * 2005-09-28 2015-11-11 Nordisk Rebalance A/S Treatment of IBS using both probiotic bacteria and fermented cereal as treatment effectors
JP5413819B2 (ja) * 2008-02-08 2014-02-12 国立大学法人広島大学 肝機能改善剤およびその製造用ツール、ならびにこれらの利用
KR101075558B1 (ko) * 2008-12-03 2011-10-20 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
KR101075557B1 (ko) 2008-12-03 2011-10-20 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
WO2010064434A1 (ja) * 2008-12-03 2010-06-10 国立大学法人広島大学 肝機能障害予防剤
KR101255050B1 (ko) 2009-07-14 2013-04-16 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
KR101486999B1 (ko) * 2009-07-22 2015-01-28 씨제이제일제당 주식회사 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
CN102618456B (zh) * 2012-02-28 2013-08-21 江南大学 一种能够缓解慢性酒精性肝损伤的鼠李糖乳杆菌及其用途
TWI463986B (zh) * 2012-08-29 2014-12-11 Univ China Medical 胚芽乳酸桿菌ｃｍｕ９９５菌株之新用途
US11633486B2 (en) 2017-04-17 2023-04-25 The University Of Chicago Polymer materials for delivery of short-chain fatty acids to the intestine for applications in human health and treatment of disease
WO2023104887A1 (en) * 2021-12-09 2023-06-15 Société des Produits Nestlé S.A. Lactobacillus acidophilus to increase agmatine production by microbiota

Also Published As

Publication number Publication date
AU5784696A (en) 1996-11-29
DE69622855D1 (de) 2002-09-12
NO317668B1 (no) 2004-11-29
JPH11504936A (ja) 1999-05-11
ATE221783T1 (de) 2002-08-15
CN1152678C (zh) 2004-06-09
PL323320A1 (en) 1998-03-16
NO975136D0 (no) 1997-11-07
DE825869T1 (de) 1998-07-16
CN1190346A (zh) 1998-08-12
JP4058560B2 (ja) 2008-03-12
WO1996035440A1 (en) 1996-11-14
ES2112818T1 (es) 1998-04-16
EP0825869B1 (en) 2002-08-07
EP0825869A1 (en) 1998-03-04
CA2220498A1 (en) 1996-11-14
PL184603B1 (pl) 2002-11-29
GR980300028T1 (en) 1998-04-30
DE69622855T2 (de) 2003-04-10
NO975136L (no) 1997-11-07
BR9608284A (pt) 1999-06-08
EE9700269A (et) 1998-04-15
KR19990008403A (ko) 1999-01-25
AU704886B2 (en) 1999-05-06
EE03597B1 (et) 2002-02-15
SE9501719D0 (sv) 1995-05-09

Similar Documents

Publication Publication Date Title
ES2112818T3 (es) Composicion farmaceutica que comprende lactobacillus plantarum y arginina.
AR016798A1 (es) Uso de una cepa de lactobacillus para la elaboracion de un medicamento
TR200101699T2 (tr) Urogenital enfeksiyonların önlenmesi ve tedavisi için ağızdan lactobakilus uygulaması
HUT75555A (en) Lactobacillus strains of human origin, their compositions and uses thereof
MY120501A (en) Micro-encapsulated lactobacilli for medical applications
DE69831578D1 (de) Lactobacillus casei rhamnosus-haltige pharmazeutische formulierung
BR0112685A (pt) Composição nutricional
ES2074698T3 (es) Composicion oral para el tratamiento de enfermedades intestinales inflamatorias.
DE69839993D1 (de) Probiotisches milchsäurebakterium zur behandlung bakterieller infektionen in zusammenhang mit sids
HUP0200206A2 (hu) Tejsavbaktérium-törzsek hasmenés megelőzésére
NO981746L (no) Utlevering av biologisk aktive polypeptider
BR0206689A (pt) Combinação de probióticos, e, uso desta
HUP9901707A2 (hu) Gasztrointesztinális rendellenességek megelőzésére és kezelésére szolgáló gyógyászati, és diétás készítmények
HUP0104410A2 (hu) Ateroszklerózis megelőzésére és/vagy kezelésére szolgáló gyógyszerkészítmények
BR9709838A (pt) Regime de administração que fornece um perfil de plasma no sangue de um inibidor de h+,k+-atpase composição farmacêutica oral uso da mesma e de inibidor h+,k+-atpase e processos para melhorar a inibição de secreção de ácido gástrico e o efeito terapêutico no tratamento de perturbações gastrintestinais e para receber um perfil estendido de plasma de um inibidor de h+,k+-atpase
NO990934L (no) Anvendelse av arakidonsyre og/eller dokosaheksansyre for fremstilling av et medikament for behandling av dyspraksi
BR0111506A (pt) Complexos de droga macromoleculares e composições contendo os mesmos
HUP9901353A2 (hu) ACE-inhibitorok alkalmazása diszpepsziás tünetek kezelésére alkalmas gyógyszerkészítmény előállítására
AR034920A1 (es) Metodos para el tratamiento de enfermedades intestinales inflamatorias
BR9506507A (pt) Forma galênica de derivados de 5-nitro-imadazol composiçoes farmacêuticas microgrânulos gastro-protegidos de derivados de 5-nitro-imidazol e produto da combinaçao
IT1274733B (it) Ceppo del genere lactobacillus di origine umana e suoi usi
AU1756299A (en) Use of putamen ovi
BR0007901A (pt) Método para a preservação ou redução deeventos cardiovasculares associados comintervenção coronária
UA31364A (uk) Спосіб лікування дисбактеріозу кишечнику у хворих на гострий пієлонефрит